Track Cartalax in Peptimes™
Cartalax is a synthetic peptide of three amino acids: alanyl-glutamyl-aspartic acid (Ala-Glu-Asp, AED). The US National Library of Medicine's MeSH vocabulary lists Cartalax as one of its names. (Source: NLM MeSH.)
Is Cartalax FDA-approved?
No. Cartalax isn't FDA-approved: Drugs@FDA lists no application with Cartalax (Ala-Glu-Asp) as an active ingredient.
Cartalax
Also: AED, Ala-Glu-Asp, alanyl-glutamyl-aspartic acid, T-31 peptide
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- SubcutaneousIntramuscularOralSublingualNasalTopicalOther
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- In animals or the lab
In human skin cells ageing in culture, AED lowered MMP-9, an enzyme that breaks down tissue, raised markers of cell growth and renewal, and reduced one form of cell death. A lab study from its developers' institute.
Source: PMID 27259496, checked 1 Nov 2026
- In animals or the lab
In human stem cells ageing in culture, AED switched on genes and proteins of cartilage-cell development (SOX9, aggrecan, type II collagen, COMP). A lab study from its developers' institute.
Source: PMID 37782646, checked 1 Nov 2026
- In animals or the lab
In old rats, AED increased urine output and lowered protein in the urine. An animal study with its developers' group.
Source: PMID 30607912, checked 1 Nov 2026
How to track it in Peptimes
Add Cartalax in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Routes: its route isn’t established, so you can choose any route the app offers. Choose the one that matches each dose.
- Logging: the amount you took, the route and how you feel.
- Injection sites: injected doses record the site, and Insights shows where you’ve injected and how recently. It never suggests where to inject next. Other routes skip this step.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Cartalax or any other compound.
More sources
- NLM, MeSH, alanyl-glutamyl-aspartic acid, checked 1 Nov 2026: a synthetic peptide, with the entry terms cartalax, Ala-Glu-Asp and T-31 peptide.
- Khavinson and colleagues, Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers, a review from its developers’ group, read 1 Nov 2026: lists Cartalax as the peptide AED.
- FDA, Drugs@FDA, checked 1 Nov 2026: no application lists Cartalax or Ala-Glu-Asp as an active ingredient.
- NIH, ClinicalTrials.gov, studies of Cartalax, checked 1 Nov 2026: no registered study.